Phase 2 Study of TD-9855 to Treat Fibromyalgia

Summary

The purpose of this study study is to determine whether TD-9855 is effective in treating patients with fibromyalgia.

Timeline

Start

2012-11

Primary completion

2014-01

Completion

2014-04

Publications

• Kanodia J, Lo A, Baldwin RM, Graham RA, Bourdet DL. Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain. Clin Pharmacokinet. 2021 Jan;60(1):121-131. doi: 10.1007/s40262-020-00918-7.

Drugs

Indications